Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices 34539 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

• For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements: Study number, study period, 

design, methodology, indication and 

diagnosis, proper use instructions, 

inclusion and exclusion criteria, 

primary and secondary outcomes, 

baseline characteristics, number of 

patients screened/eligible/enrolled/lost 

to follow-up/withdrawn/analyzed, 

effectiveness/efficacy, and safety results. 

• A list of ongoing studies your 

company has sponsored for this 

indication. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including a study number, the 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, and primary and secondary 

outcomes. 

• Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

company for this indication and an 

index outlining the relevant information 

in each submitted file. 

Your contribution is very beneficial to 

the Program. The contents of all 

submissions will be made available to 

the public upon request. Materials 

submitted must be publicly available or 

can be made public. Materials that are 

considered confidential; marketing 

materials; study types not included in 

the review; or information on 

indications not included in the review 

cannot be used by the Effective Health 

Care Program. This is a voluntary 

request for information, and all costs for 

complying with this request must be 

borne by the submitter. 

The draft of this review will be posted 

on AHRQ’s EHC program Web site and 

available for public comment for a 

period of 4 weeks. If you would like to 

be notified when the draft is posted, 

please sign up for the email list at: 

http://effectivehealthcare.AHRQ.gov/

index.cfm/join-the-email-list1/. 

The systematic review will answer the 

following questions. This information is 

provided as background. AHRQ is not 

requesting that the public provide 

answers to these questions. The entire 

research protocol, is also available 

online at: http://effectivehealth

care.AHRQ.gov/search-for-guidesreviews-and-reports/

?pageaction=displayproduct&

productID=1906#8766. 

Key Questions (KQs) 

1. What methods are available to 

clinicians to diagnose ME/CFS and how 

do the use of these methods vary by 

patient subgroups? 

A. What are widely accepted 

diagnostic methods and what conditions 

are required to be ruled out or excluded 

before assigning a diagnosis of ME/CFS? 

B. What is the accuracy and 

concordance of diagnostic methods? 

C. What harms are associated with 

diagnosing ME/CFS? 

2. What are the (a) benefits and (b) 

harms of therapeutic interventions for 

patients with ME/CFS and how do they 

vary by patient subgroups? 

A. What are the characteristics of 

responders and non-responders to 

interventions? 

PICOTS (Population, Intervention, 

Comparator(s), Outcomes, Timing, 

Setting) 

Population(s) 

1. Include: 

A. For KQ 1: Symptomatic adults (aged 

18 years or older) with fatigue 

B. For KQ 2: Adults aged 18 years or 

older, with ME/CFS, without other 

underlying diagnosis 

2. Exclude: 

A. Children and adolescents 

B. Patients with other underlying 

diagnosis 

Interventions 

1. Include: 

A. For KQ1: Case definitions: e.g., 

Fukada/CDC, Canadian, International 

and others 

For KQ2: symptom-based medication 

management (immune modulators, 

beta blockers, antidepressants, 

anxiolytics, stimulants), forms of 

counseling and behavior therapy, 

graded exercise programs, 

complementary and alternative 

medicine (acupuncture, relaxation, 

massage, or other), and 

transcutaneous electrical nerve 

stimulation. 

Comparators 

1. Include: 

A. For KQ1: Diagnostic accuracy studies 

and diagnostic concordance studies 

with comparators 

B. For KQ2: Placebo or no treatment/

usual care, other active interventions 

(including combination therapies and 

head-to-head trials) 

Outcomes 

1. Include: 

A. For KQ1: Sensitivity, specificity, 

positive predictive value, negative 

predictive value, positive likelihood 

ratio, negative likelihood ratio, C 

statistic (AUROC), net reclassification 

index; concordance, any potential 

harm from diagnosis (such as 

psychological harms, labeling, risk 

from diagnostic test, misdiagnosis, 

other) 

B. For KQ2: Overall function (i.e., 36- 

item Short Form Survey [SF–36]), 

quality of life, days spent at work/

school, proportion working full or 

part time, fatigue (Multidimensional 

Fatigue Inventory [MFI] or similar), 

adverse effects of interventions, 

withdrawals and withdrawals due to 

adverse events, rates of adverse events 

due to interventions 

Timing 

1. Include: 12 weeks or longer 

Setting 

1. Include: Clinical settings 

Dated: June 3, 2014. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2014–14084 Filed 6–16–14; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare and Medicaid 

Services 

Privacy Act of 1974; Report of New 

System of Records 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Department 

of Health and Human Services (HHS). 

ACTION: Notice of New System of 

Records (SOR). 

SUMMARY: In accordance with the 

requirements of the Privacy Act of 1974, 

we are proposing to establish a new 

SOR, titled ‘‘CMS Encounter Data 

System (EDS)’’, System No. 09–70–0506. 

CMS intends to collect encounter data, 

or data on each item or service delivered 

to enrollees of Medicare Advantage 

(MA) plans offered by MA organizations 

as defined at Title 42, Code of Federal 

Regulation (CFR), § 422.4. Pursuant to 

42 CFR 422.310, each MA organization 

must submit encounter data to CMS that 

is used to determine the risk adjustment 

factors for payment, updating the risk 

adjustment model, calculating Medicare 

Disproportionate Share Hospital (DSH) 

percentages, Medicare coverage 

purposes, and quality review and 

improvement activities. Encounter data 

will be collected and maintained in the 

EDS. 

Under the authority granted in 

Section 1115 of the Social Security Act 

(the Act), CMS is authorized to conduct 

experimental, pilot or demonstration 


tkelley on DSK3SPTVN1PROD with NOTICES
34540 Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices 

projects. CMS is conducting a 

demonstration project under the 

Financial Alignment Initiative to test a 

new capitated payment system and 

item/service delivery model designed to 

lower costs and improve the quality of 

care for individuals eligible for both 

Medicare and Medicaid (dual eligibles). 

CMS and the participating State 

Medicaid agency jointly contract with 

health plans (known as MedicareMedicaid Plans or ‘‘MMPs’’). MMPs are 

paid monthly on a capitated basis and 

are required to submit to CMS 

comprehensive encounter data on each 

item or service provided to each 

enrollee, including both Medicare and 

Medicaid items and services. The 

program and the SOR are more 

thoroughly described in the 

Supplemental Information section and 

System of Records Notice (SORN), 

below. 

DATES: Effective 30 days after 

publication. Written comments should 

be submitted on or before the effective 

date. HHS/CMS/CM may publish an 

amended SORN in light of any 

comments received. 

ADDRESSES: The public should send 

comments to: CMS Privacy Officer, 

Division of Privacy Policy, Privacy 

Policy and Compliance Group, Office of 

E-Health Standards and Services, 

Offices of Enterprise Management, CMS, 

Room S2–24–25, 7500 Security 

Boulevard, Baltimore, Maryland 21244– 

1850. Comments received will be 

available for review at this location, by 

appointment, during regular business 

hours, Monday through Friday from 

9:00 a.m.–3:00 p.m., Eastern Time zone. 

FOR FURTHER INFORMATION CONTACT: 

Shari Kosko, Division of Encounter Data 

and Risk Adjustment Operations, 

Medicare Plan Payment Group, Center 

for Medicare, Centers for Medicare & 

Medicaid Services, Mail Stop C1–13–07, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. The telephone 

number is (410) 786–6159 or email: 

Shari.Kosko@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: Medicare 

beneficiaries who receive both Part A 

and Part B benefits may elect to receive 

their Medicare coverage by enrolling in 

a plan offered by a MA organization or 

certain other Medicare private plans. 

MA plans must provide all Medicarecovered items and services, and may 

also provide additional benefits not 

covered by Original Medicare. CMS 

pays MA organizations on a monthly 

capitated rate for each beneficiary 

enrolled, and the MA organizations are 

responsible for paying providers for 

items and services that are provided to 

enrolled beneficiaries. All MA 

organizations are required to submit 

encounter data that CMS uses to adjust 

the advanced monthly payments made 

to the MA organization. 

CMS will collect encounter data for 

all items and services provided to MA 

plan enrollees covered by all MA 

organizations in the states where the 

demonstration projects are being 

conducted. In the case of cost plans, 

only encounter data for items and 

services covered by the plans will be 

collected. None of the data that will be 

included in the EDS will come from 

Medicare Part A or Part B data, nor will 

any additional identifiers be provided in 

the EDS data submitted by the MA 

organizations. However, the data 

submitted to EDS will be provided into 

the Integrated Data Repository (IDR) and 

will be available along with Medicare 

Part A and Part B data. 

Beginning with calendar year 2007, 

100 percent of monthly payments to MA 

organizations have been subject to 

adjustment based on risk adjustment 

factors. Given the increased importance 

of the accuracy of our risk adjustment 

methodology, CMS amended 42 CFR 

422.310 in August of 2008 to authorize 

the collection of data from MA 

organizations regarding each item and 

service provided to a MA plan enrollee. 

Once encounter data for MA enrollees 

are available in the EDS, CMS will have 

beneficiary-specific information on the 

utilization of items and services by MA 

plan enrollees. These data will 

primarily be used to develop and 

calibrate the CMS hierarchical condition 

categories (CMS–HCC) for risk 

adjustment models using MA patterns of 

diagnoses and expenditures. These new 

models will be used to calculate the risk 

adjustment factors used to adjust 

advanced monthly payments to MA 

plans made by CMS on behalf of 

beneficiaries. The data will also be used 

for other purposes such as calculating 

Disproportionate Share Hospital (DSH) 

payments and quality improvement 

activities, etc. as outlined in 42 CFR 

422.310(f). 

The types of MA organizations that 

CMS collects encounter data from 

include: coordinated care plans 

(including Special Needs Plans), private 

fee for service plans, and a combination 

of a MA Medical Savings Account 

(MSA) and a contribution into a MA 

MSA established in accordance with 42 

CFR 422.262. These categories also 

include Medicare AdvantagePrescription Drug plans, Program-of-AllInclusive-Care-for-the-Elderly-(PACE) 

organizations, Employer Group Health 

Plans (EGHPs), Section 1833 health care 

prepayment plans (HCPPs) and Section 

1876 plans operated by an HMO or 

Competitive Medical Plan (HMO/CMP) 

(42 U.S.C. 1833 and 42 U.S.C. 1876, 

referred to collectively as ‘‘cost plans’’). 

The encounter data that CMS collects 

includes, the identity of the Medicare 

beneficiary, the provider, the place of 

service, and the item or service 

provided. In addition to identifying 

information about the beneficiary and 

provider, other significant data elements 

submitted by the MA organization 

include, claim pricing information, 

contact information, service provider 

information, revenue center codes, 

modifiers, Healthcare Common 

Procedure Coding System (HCPCS) 

codes, and Current Procedural 

Terminology (CPT) codes. 

The Privacy Act 

The Privacy Act (5 U.S.C. 552a) 

governs the means by which the United 

States Government maintains personally 

identifiable information (PII) in a system 

of records. A ‘‘system of records’’ is a 

group of any records under the control 

of a Federal agency from which 

information about individuals is 

retrieved by name or other personal 

identifier. The Privacy Act requires each 

agency to publish in the Federal 

Register a system of records notice 

(SORN) identifying and describing each 

system of records the agency maintains, 

including a description of the categories 

of records maintained in the system, the 

source(s) of records in the system, the 

purposes for which the agency uses PII 

in the system, the routine uses for 

which the agency discloses such 

information outside the agency, and 

how individual record subjects can 

exercise their rights under the Privacy 

Act (e.g., to determine if the system 

contains information about them). 

SYSTEM NUMBER: 09–70–0506 

SYSTEM NAME: 

CMS Encounter Data System (EDS), 

HHS/CMS/CM. 

SECURITY CLASSIFICATION: 

Sensitive, unclassified. 

SYSTEM LOCATION: 

CMS Data Center, 7500 Security 

Boulevard, North Building, First Floor, 

Baltimore, Maryland 21244–1850; CDS 

Columbia Data Center EDC2, I–20 at 

Alpine Road, AA–278, Columbia, SC 

29219; and at various contractor sites. 

CATEGORIES OF INDIVIDUALS COVERED BY THE

SYSTEM: 

Information maintained in this system 

includes identifying information of 

individuals and beneficiaries who have 

enrolled in a MA plan (including 

coordinated care plans, Special Needs 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices 34541 

Plans, private fee for service plans, 

Medicare Medical Savings Accounts, 

PACE organizations, MMPs, and MA– 

PD plans) (Medicare Advantage plus 

Part D plans) (collectively, ‘‘MA plan 

enrollees’’), whose information is 

reported by a Medicare provider, 

supplier, physician, or other 

practitioner. It also includes identifying 

information of those health care 

professionals who provide the items or 

services to individuals during a service 

year. 

CATEGORIES OF RECORDS IN THE SYSTEM: 

The system contains the name and 

other identifying information of the MA 

plan enrollee, beneficiary; and the 

name, work address, work phone 

number, social security number, 

National Provider Identification Number 

(NPI) of servicing providers, supplier, 

physician, or other practitioner. CMS 

will collect the admission date, 

discharge date, health insurance claim 

number (HICN), Medicare hospital 

number/CCN (CMS Certification 

Number) and other identifying 

demographics of individuals necessary 

to characterize the context and purposes 

of each item and service provided to a 

Medicare enrollee by a provider, 

supplier, physician, or other 

practitioner. MA plans will make data 

collection changes from 5 data elements 

currently collected to all of the required 

data elements on the HIPAA 5010 

version of the X12 standards. 

AUTHORITY FOR MAINTENANCE OF THE SYSTEM: 

Section 1853(a)(3)(B) of the Act 

requires that MA organizations and 

certain other private Medicare plans 

submit data regarding inpatient hospital 

and other services that CMS deems 

necessary to risk adjust these payments. 

The final 2009 Inpatient Prospective 

Payment System rule (73 FR 48757, 

August 19, 2008) modified 42 CFR 

422.310 to clarify that the Secretary has 

the authority to require MA 

organizations and other private plans to 

submit encounter data for each item and 

service provided to a MA plan enrollee. 

Information for the Financial Alignment 

Initiative is being collected from MA 

plans that provide an integrated set of 

Medicare and Medicaid services 

through the demonstration project 

authorized under section 1115 of the 

Act. 

PURPOSE(S) OF THE SYSTEM: 

The primary purpose of the SOR is to 

collect and maintain encounter data for 

each item and service provided to MA 

plan enrollees reported by a Medicare 

provider, supplier, physician, or other 

practitioner. CMS will collect 

information necessary to determine the 

risk adjustment factors used to adjust 

payments, calculate Medicare DSH 

percentages, conduct quality review and 

improvement activities, and for other 

Medicare coverage purposes. 

Information retrieved from this SOR 

will also be disseminated or disclosed 

to: (1) Support regulatory, 

reimbursement, and policy functions 

performed within the Agency or by a 

contractor, consultant, or a CMS 

grantee; (2) assist another Federal 

agency, agency of a state government, an 

agency established by state law, or its 

fiscal agent; (3) assist MA plans with 

required collection of encounter data 

obtained from the provider, supplier, 

physician, or other practitioner that 

furnished the item or service; (4) 

support an individual or organization 

for a research; (5) support litigation 

involving the Agency related to this 

SOR; (6) to assist a contractor combat 

fraud, waste, and abuse in certain health 

care programs; (7) to assist another 

Federal agency combat fraud, waste, and 

abuse; (8) to assist appropriate Federal 

agencies and CMS contractors and 

consultants to assist in CMS’ efforts to 

respond to a suspected or confirmed 

breach; (9) assist the U.S. Department of 

Homeland Security (DHS) cyber security 

personnel; and (10) assist with 

emergency preparedness. 

ROUTINE USES OF RECORDS MAINTAINED IN THE

SYSTEM, INCLUDING CATEGORIES OR USERS AND

THE PURPOSES OF SUCH USES: 

ENTITIES WHO MAY RECEIVE DISCLOSURES UNDER

ROUTINE USES

These routine uses specify 

circumstances, in addition to those 

provided by statute in the Privacy Act 

of 1974, under which CMS may release 

information from the EDS without the 

consent of the individual to whom such 

information pertains. Each proposed 

disclosure of information under these 

routine uses will be evaluated to ensure 

that the disclosure is legally permissible 

under 42 CFR 422.310, including but 

not limited to ensuring that the purpose 

of the disclosure is compatible with the 

purpose for which the information was 

collected. We propose to establish the 

following routine use disclosures of 

information maintained in the system: 

1. To Agency contractors, consultants, 

or CMS grantees who have been engaged 

by the Agency in order to support them 

in accomplishment of a CMS function 

relating to the purposes for this 

collection and who need to have access 

to the records in order to assist CMS. 

2. To another Federal agency, agency 

of a state government, an agency 

established by state law, or its fiscal 

agent in order to: 

a. Contribute to the accuracy of CMS’ 

proper payment of Medicare benefits, 

b. enable such agency to administer a 

Federal health benefits program, or as 

necessary to enable such agency to 

fulfill a requirement of a Federal statute 

or regulation that implements a health 

benefits program funded in whole or in 

part with Federal funds, and/or 

c. fulfill oversight, regulatory, or 

policy functions performed by such 

agency. 

3. To assist MA plans with the 

required collection of encounter data, 

which is to be obtained from the 

provider, supplier, physician, or other 

practitioner that furnished the item or 

service. 

4. To an individual or organization to 

support or assist them with (a) a 

research, evaluation or epidemiological 

project related to the prevention of 

disease or disability, the restoration or 

maintenance of health, (b) payment 

related projects, and (c) analysis of the 

provision of health services. 

5. To provide information to the U.S. 

Department of Justice (DOJ), a court, or 

an adjudicatory body when (a) CMS or 

any component thereof, or (b) any 

employee of CMS in his or her official 

capacity, or (c) any employee of CMS in 

his or her individual capacity where the 

DOJ has agreed to represent the 

employee, or (d) the United States 

Government, is a party to litigation or 

has an interest in such litigation, and by 

careful review, CMS determines that the 

records are both relevant and necessary 

to the litigation and that the use of such 

records by the DOJ, court, or 

adjudicatory body is compatible with 

the purpose for which the agency 

collected the records. 

6. To a CMS contractor (including but 

not limited to Medicare Administrative 

Contractors) that assists in the 

administration of a CMS-administered 

health benefits program, or to a grantee 

of a CMS-administered grant program, 

when disclosure is deemed reasonably 

necessary by CMS to prevent, deter, 

discover, detect, investigate, examine, 

prosecute, sue with respect to, defend 

against, correct, remedy, or otherwise 

combat fraud, waste or abuse in such 

program. 

7. To another Federal agency or to an 

instrumentality of any governmental 

jurisdiction within or under the control 

of the United States (including any state 

or local governmental agency), that 

administers or that has the authority to 

investigate potential fraud, waste or 

abuse in a health benefits program 

funded in whole or in part by Federal 

funds, when disclosure is deemed 

reasonably necessary by CMS to 

prevent, deter, discover, detect, 


tkelley on DSK3SPTVN1PROD with NOTICES
34542 Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices 

investigate, examine, prosecute, sue 

with respect to, defend against, correct, 

remedy, or otherwise combat fraud, 

waste or abuse in such programs. 

8. To appropriate Federal agencies 

and CMS contractors and consultants 

that have a need to know the 

information for the purpose of assisting 

CMS’ efforts to respond to a suspected 

or confirmed breach of the security or 

confidentiality of information 

maintained in this SOR, provided that 

the information disclosed is relevant 

and necessary for that assistance. 

9. To the U.S. Department of 

Homeland Security (DHS) cyber security 

personnel, if captured in an intrusion 

detection system used by HHS and DHS 

pursuant to the Einstein 2 programs. 

10. To disclose the personally 

identifiable information of MA plan 

enrollees to public health authorities, 

and those entities acting under a 

delegation of authority from a public 

health authority, when requesting such 

information to carry out statutorilyauthorized public health activities 

pertaining to emergency preparedness 

and response. Disclosures under this 

routine use will be limited to ‘‘public 

health authorities’’, ‘‘public health 

activities’’, and ‘‘minimum necessary 

data’’, as defined in the HIPAA Privacy 

Rule (45 CFR 154.502, 164.512(b), 

164.502(b) and 164.514(d)(3)(iii)(A)). 

POLICIES AND PRACTICES FOR STORING, 

RETRIEVING, ACCESSING, RETAINING, AND

DISPOSING OF RECORDS IN THE SYSTEM

STORAGE: 

All records are stored on magnetic 

media. 

RETRIEVABILITY: 

All records are accessible by NPI/

NPPES or by beneficiary HICN. This 

system supports both on-line and batch 

access. The EDS system itself does not 

provide reporting capabilities. All 

reporting functionality can be found in 

the IDR. 

SAFEGUARDS: 

Personnel having access to the system 

have been trained in the Privacy Act 

and information security requirements. 

Employees who maintain records in this 

system are instructed not to release data 

until the intended recipient agrees to 

implement appropriate management, 

operational, and technical safeguards 

sufficient to protect the confidentiality, 

integrity and availability of the 

information and information systems, 

and to prevent unauthorized access. 

Access to records in the EDS will be 

limited to CMS personnel and approved 

contractors. 

RETENTION AND DISPOSAL: 

Records containing PII will be 

maintained for a period of up to 10 

years after entry in the database. Any 

such records that are needed longer, 

such as to resolve claims and audit 

exceptions or to prosecute fraud, will be 

retained until such matters are resolved. 

Enrollee claims records are currently 

subject to a document preservation 

order and will be preserved indefinitely 

pending further notice from the DOJ. 

SYSTEM MANAGER AND ADDRESS: 

Director, Division of Risk Adjustment 

Payment and Policy, Medicare Plan 

Payment Group, Center for Medicare, 

Centers for Medicare & Medicaid 

Services. 

NOTIFICATION PROCEDURE: 

Individuals wishing to know if this 

system contains records about them 

should write to the system managers 

and include the pertinent personal 

identifier used for retrieval of their 

records (i.e., TIN, NPI or HICN). 

RECORD ACCESS PROCEDURE: 

Individuals seeking access to records 

about them in this system should follow 

the same instructions indicated under 

‘‘Notification Procedure’’ and 

reasonably specify the record contents 

being sought. (These procedures are in 

accordance with HHS Privacy Act 

regulations at 45 CFR 5b.5 (a)(2)). 

CONTESTING RECORD PROCEDURES: 

Individuals seeking to contest the 

content of information about them in 

this system should follow the same 

instructions indicated under 

‘‘Notification Procedure.’’ The request 

should reasonably identify the record 

and specify the information being 

contested; state the corrective actions 

sought, and provide the reasons for the 

correction, with supporting justification. 

(These procedures are in accordance 

with HHS Privacy Act regulations at 45 

CFR 5b.7). 

RECORD SOURCE CATEGORIES: 

Sources of information contained in 

this records system include data 

collected from MA organizations and 

encounter data obtained from the 

provider, supplier, physician, or other 

practitioner that furnished the item or 

service. 

SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS

OF THE ACT: 

None. 

Celeste Dade-Vinson, 

Health Insurance Specialist, Centers for 

Medicare & Medicaid Services. 

[FR Doc. 2014–14038 Filed 6–16–14; 8:45 am] 

BILLING CODE 4120–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel, NEI Cornea and 

Anterior Eye Grant Applications. 

Date: July 21, 2014. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Anne E Schaffner, Ph.D., 

Chief, Scientific Review Branch Division of 

Extramural Research, National Eye Institute, 

5635 Fishers Lane, Suite 1300, MSC 9300, 

Bethesda, MD 20892–9300, (301) 451–2020, 

aes@nei.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS). 

Dated: June 12, 2014. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–14109 Filed 6–16–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 


tkelley on DSK3SPTVN1PROD with NOTICES